May 22, 2023
Peter Marks, MD, PhD, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, will join an AABB Hot Topic Discussion from 2-3 p.m. ET on Thursday to provide an update on FDA’s recent final guidance on individual donor assessment.
Following Marks’s presentation, Sharon Carayiannis, MT(ASCP)HP, AABB’s vice president, science and practice, will moderate a question-and-answer session.
Registration is complimentary but required.